Literature DB >> 6631409

Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures.

H Anwar, M R Brown, P A Lambert.   

Abstract

Pseudomonas cepacia grown under different specific nutrient depletions in batch culture showed varying degrees of sensitivity to engulfment and killing by human polymorphonuclear leukocytes (PMN) and to killing by human serum. Resistance to killing by the combined action of PMN and serum in while blood was found to increase in the following order of depletions: glucose less than iron less than sulphate less than phosphate or ammonium less than magnesium. There was also an increase in resistance to killing by whole blood with decrease in temperature, except that carbon-depleted cells remained very sensitive irrespective of temperature. Cells in the exponential phase of growth also showed a consistent increase in resistance as the temperature was decreased. Similar, but smaller effects were observed with oxygen-depleted cells. The increase in killing by whole blood as the phagocytic temperature was raised correlated with an increase in the number of bacteria ingested per PMN. A pattern of serum sensitivity was observed with cells grown under different nutrient depletions similar to that for whole blood. But in all cases whole blood was 6 to 10 times more effective than serum alone in killing the cells at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631409     DOI: 10.1099/00221287-129-7-2021

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  13 in total

1.  Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex.

Authors:  S Häussler; C Lehmann; C Breselge; M Rohde; M Classen; B Tümmler; P Vandamme; I Steinmetz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-28       Impact factor: 3.267

2.  The effects of purified 25-kDa lipase from a clinical isolate of Pseudomonas cepacia in the lungs of rats.

Authors:  M K Lonon; D E Woods; D C Straus
Journal:  Curr Microbiol       Date:  1992-08       Impact factor: 2.188

Review 3.  Testing the susceptibility of bacteria in biofilms to antibacterial agents.

Authors:  H Anwar; M K Dasgupta; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 4.  Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.

Authors:  M R Brown; P J Collier; P Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa.

Authors:  H Anwar; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Influence of cephalosporins and iron on surface protein antigens of Klebsiella pneumoniae in vivo.

Authors:  J L Kadurugamuwa; H Anwar; M R Brown; B Hengstler; S Kunz; O Zak
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

9.  In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions.

Authors:  G H Shand; H Anwar; J Kadurugamuwa; M R Brown; S H Silverman; J Melling
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

10.  Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.

Authors:  S Lewenza; B Conway; E P Greenberg; P A Sokol
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.